Business Description
Zoetis Inc
NAICS : 325412
SIC : 2834
ISIN : US98978V1035
Share Class Description:
LTS:0M3Q: Class ACompare
Compare
Traded in other countries / regions
ZTS.USAZ1TS34.BrazilZTS.MexicoZOE.GermanyZOTS.Austria1ZTS.Italy0M3Q.UK IPO Date
2018-01-18Description
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.3 | |||||
| Equity-to-Asset | 0.35 | |||||
| Debt-to-Equity | 1.35 | |||||
| Debt-to-EBITDA | 1.84 | |||||
| Interest Coverage | 12.84 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 7.16 | |||||
| Beneish M-Score | -2.36 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 9.8 | |||||
| 3-Year EBITDA Growth Rate | 12.5 | |||||
| 3-Year EPS without NRI Growth Rate | 11.4 | |||||
| 3-Year FCF Growth Rate | 0.1 | |||||
| 3-Year Book Growth Rate | 11.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 10.1 | |||||
| Future 3-5Y Total Revenue Growth Rate | 6.55 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.36 | |||||
| Quick Ratio | 2 | |||||
| Cash Ratio | 1.08 | |||||
| Days Inventory | 368.19 | |||||
| Days Sales Outstanding | 53.69 | |||||
| Days Payable | 59.63 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Dividend Growth Rate | 23.3 | |||||
| 3-Year Average Share Buyback Ratio | 1.2 | |||||
| Shareholder Yield % | 3.15 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 70.03 | |||||
| Operating Margin % | 35.92 | |||||
| Net Margin % | 27.43 | |||||
| FCF Margin % | 18.97 | |||||
| ROE % | 49.66 | |||||
| ROA % | 16.55 | |||||
| ROIC % | 23.25 | |||||
| ROC (Joel Greenblatt) % | 55.82 | |||||
| ROCE % | 26.25 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 29.76 | |||||
| Forward PE Ratio | 26.16 | |||||
| PE Ratio without NRI | 28.36 | |||||
| Shiller PE Ratio | 46.23 | |||||
| Price-to-Owner-Earnings | 38.69 | |||||
| PEG Ratio | 2.34 | |||||
| PS Ratio | 8.16 | |||||
| PB Ratio | 13.84 | |||||
| Price-to-Tangible-Book | 76.93 | |||||
| Price-to-Free-Cash-Flow | 42.95 | |||||
| Price-to-Operating-Cash-Flow | 29.61 | |||||
| EV-to-EBIT | 23.2 | |||||
| EV-to-EBITDA | 20.09 | |||||
| EV-to-Revenue | 8.62 | |||||
| EV-to-FCF | 45.44 | |||||
| Price-to-Projected-FCF | 2.79 | |||||
| Price-to-DCF (Earnings Based) | 1.37 | |||||
| Price-to-DCF (FCF Based) | 2.19 | |||||
| Price-to-Median-PS-Value | 1.01 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.36 | |||||
| Price-to-Graham-Number | 9.84 | |||||
| Earnings Yield (Greenblatt) % | 4.31 | |||||
| FCF Yield % | 2.35 | |||||
| Forward Rate of Return (Yacktman) % | 14.21 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Zoetis Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 8,544 | ||
| EPS (TTM) ($) | 5.07 | ||
| Beta | 0.1 | ||
| Volatility % | 0.32 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0 | ||
| 20-Day SMA ($) | 207.7 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 207.7 - 207.7 | ||
| Shares Outstanding (Mil) | 456.95 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Zoetis Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Zoetis Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Zoetis Inc Frequently Asked Questions
What is Zoetis Inc(LTS:0M3Q)'s stock price today?
The current price of LTS:0M3Q is $207.70. The 52 week high of LTS:0M3Q is $207.70 and 52 week low is $207.70.
When is next earnings date of Zoetis Inc(LTS:0M3Q)?
The next earnings date of Zoetis Inc(LTS:0M3Q) is 2024-05-02.
Does Zoetis Inc(LTS:0M3Q) pay dividends? If so, how much?
Zoetis Inc(LTS:0M3Q) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers